Today's Daily Dose brings you news about FDA approval of a seborrheic keratoses product; lifting of clinical hold on Fitusiran trials; disappointing trial results of a pet therapeutics company; an update on the patent infringement suit related to Oxford Immunotec's T-SPOT TB test, a method for diagnosing TB infection, and Verastem's stock offering.
from RTT - Biotech http://ift.tt/2AQ6AAA
via IFTTT
No comments:
Post a Comment